These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8384114)

  • 1. The AMPA receptor antagonist NBQX exerts antidystonic effects in an animal model of idiopathic dystonia.
    Richter A; Löscher W; Löschmann PA
    Eur J Pharmacol; 1993 Feb; 231(2):287-91. PubMed ID: 8384114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intrastriatal injections of glutamate receptor antagonists on the severity of paroxysmal dystonia in the dtsz mutant.
    Sander SE; Richter A
    Eur J Pharmacol; 2007 Jun; 563(1-3):102-8. PubMed ID: 17349621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pharmacological entopeduncular manipulations on idiopathic dystonia in the dt(sz) mutant hamster.
    Hamann M; Sander SE; Kreil A; Richter A
    J Neural Transm (Vienna); 2010 Jun; 117(6):747-57. PubMed ID: 20454986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probenecid pretreatment enhances anticonvulsant action of NBQX in mice.
    Taylor CP; Vartanian MG
    Eur J Pharmacol; 1992 Mar; 213(1):151-3. PubMed ID: 1499653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NBQX, a selective antagonist of the AMPA receptor, affects neither field potentials nor long-term potentiation in vivo.
    Sato K; Morimoto K; Yamada N; Kuroda S; Hayabara T
    Brain Res; 1995 Jun; 683(2):279-82. PubMed ID: 7552367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine.
    Li Y; Vartanian AJ; White FJ; Xue CJ; Wolf ME
    Psychopharmacology (Berl); 1997 Dec; 134(3):266-76. PubMed ID: 9438676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists.
    Maj J; Rogóz Z; Skuza G; Jaros T
    Pol J Pharmacol; 1995; 47(4):269-77. PubMed ID: 8616504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of striatal NMDA receptor subunits in a model of paroxysmal dystonia.
    Avchalumov Y; Sander SE; Richter F; Porath K; Hamann M; Bode C; Kirschstein T; Köhling R; Richter A
    Exp Neurol; 2014 Nov; 261():677-84. PubMed ID: 25139804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
    Wrathall JR; Teng YD; Marriott R
    Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive inhibition by NBQX of kainate/AMPA receptor currents and excitatory synaptic potentials: importance of 6-nitro substitution.
    Randle JC; Guet T; Cordi A; Lepagnol JM
    Eur J Pharmacol; 1992 May; 215(2-3):237-44. PubMed ID: 1382998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPA receptors and motivation for drug: effect of the selective antagonist NBQX on behavioural sensitization and on self-administration in mice.
    Jackson A; Mead AN; Rocha BA; Stephens DN
    Behav Pharmacol; 1998 Sep; 9(5-6):457-67. PubMed ID: 9832931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat.
    Hu P; Diemer NH; Bruhn T; Johansen FF
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):147-52. PubMed ID: 9040493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
    Swedberg MD; Jacobsen P; Honoré T
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1113-21. PubMed ID: 7562477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors.
    Mead AN; Stephens DN
    J Pharmacol Exp Ther; 1999 Jul; 290(1):9-15. PubMed ID: 10381753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of kynurenic acid in brains of genetically dystonic hamsters.
    Richter A; Loscher W; Baran H; Gramer M
    Brain Res Dev Brain Res; 1996 Mar; 92(1):111-6. PubMed ID: 8861729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline on methamphetamine- and cocaine-induced behavioral sensitization.
    Akiyama K; Ujike H; Sakai K; Shimizu Y; Kodama M; Kuroda S
    Pharmacol Biochem Behav; 1998 Dec; 61(4):419-26. PubMed ID: 9802837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel antiepileptic drug, lamotrigine, exerts prodystonic effects in a mutant hamster model of generalized dystonia.
    Richter A; Löschmann PA; Löscher W
    Eur J Pharmacol; 1994 Nov; 264(3):345-51. PubMed ID: 7698175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPA receptor competitive antagonism reduces halothane MAC in rats.
    McFarlane C; Warner DS; Todd MM; Nordholm L
    Anesthesiology; 1992 Dec; 77(6):1165-70. PubMed ID: 1334638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NBQX inhibits AMPA-induced locomotion after injection into the nucleus accumbens.
    Boldry RC; Kelland MD; Engber TM; Chase TN
    Brain Res; 1993 Jan; 600(2):331-4. PubMed ID: 7679606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.